Skip to main content

Table 1 Baseline characteristics according to blood pressure control

From: Impact of uncontrolled hypertension on 12-month clinical outcomes following below-the-knee arteries (BTK) interventions in patients with critical limb ischemia

Variable. n%

Total (n = 165 Pts) (n = 201 Limb) (n = 246 Lesion)

Controlled HTN (n = 53 Pts) (n = 66 Limb) (n = 90 Lesion)

Uncontrolled HTN (n = 112 Pts) (n = 135 Limb) (n = 156 Lesion)

P Value

Baseline characteristics

    

Gender (Male)

128 (77.5)

43 (81.1)

85 (75.8)

0.550

Age (years)

68.2 ± 9.3

68.8 ± 10.2

67.9 ± 8.8

0.549

Body mass index (kg/m2)

23.2 ± 3.2

22.9 ± 3.4

23.3 ± 3.1

0.471

Diagnosis

    

Wound

135 (81.8)

44 (83)

91 (81.2)

0.783

Diabetic foot ulcer

124 (75.1)

41 (77.3)

83 (74.1)

0.652

Gangrene

11 (6.6)

3 (5.6)

8 (7.1)

1.000

Claudication

12 (7.2)

5 (9.4)

7 (6.2)

0.525

Resting pain

16 (9.6)

3 (5.6)

13 (11.6)

0.228

Blood pressure; BP (mmHg)

    

Systolic BP

151.7 ± 17.3

122.6 ± 13.2

165.4 ± 19.2

<0.001

Diastolic BP

76.2 ± 45.5

64.9 ± 12.4

81.5 ± 61.2

0.053

Heart rate

78.9 ± 14.7

79.1 ± 19.5

78.8 ± 12.4

0.911

Pulse pressure (mmHg)

78.6 ± 24.2

57.7 ± 0.8

83.8 ± 42.0

<0.001

Past medical and social history

    

Known HTN

116 (70.6)

35 (66.2)

81 (73.2)

0.399

Diabetes

152 (92.1)

49 (92.4)

103 (91.9)

1.000

Dyslipidemia

8 (4.8)

3 (5.6)

5 (4.4)

0.713

Cerebrovascular disease

32 (19.3)

9 (16.9)

23 (20.5)

0.676

Chronic kidney disease

55 (33.3)

20 (37.7)

35 (31.2)

0.480

Dialysis

41 (24.8)

15 (28.3)

26 (23.2)

0.563

Atrial fibrillation

15 (9.0)

5 (9.4)

10 (8.9)

1.000

Coronary artery disease

102 (61.8)

29 (54.7)

73 (65.1)

0.231

Myocardial infarction

10 (6.0)

3 (5.6)

7 (6.2)

1.000

PTCA

24 (14.5)

6 (11.3)

18 (16.0)

0.486

CABG

10 (6.0)

1 (1.8)

9 (8.0)

0.170

Smoking

66 (40.0)

21 (39.6)

45 (40.1)

1.000

Current smokers

35 (21.2)

13 (24.5)

22 (19.6)

0.542

Alcoholic

49 (29.6)

17 (32.0)

32 (28.5)

0.716

Current alcoholics

29 (17.5)

11 (20.7)

18 (16.0)

0.513

Laboratory findings

    

Fasting glucose (mg/dL)

144.2 ± 67.2

150.2 ± 71.9

141.2 ± 65.0

0.520

Hemoglobin A1c (%)

7.4 ± 1.4

7.3 ± 1.3

7.5 ± 1.4

0.318

Total cholesterol (mg/dL)

147.6 ± 44.7

146.6 ± 48.5

148.1 ± 42.9

0.842

Triglycerides (mg/dL)

129.6 ± 100.5

132.0 ± 53.0

128.4 ± 124.1

0.840

HDL cholesterol (mg/dL)

36.3 ± 11.5

35.9 ± 12.3

36.6 ± 11.2

0.725

LDL cholesterol (mg/dL)

90.0 ± 37.3

89.0 ± 38.2

90.5 ± 36.9

0.819

hsCRP (mg/L)

20.3 ± 38.6

25.3 ± 37.5

18.0 ± 39.1

0.439

Albumin (g/dL)

3.8 ± 1.6

4.1 ± 4.0

3.6 ± 0.5

0.400

Uric acid (mg/dL)

5.5 ± 1.8

5.6 ± 1.6

5.4 ± 1.8

0.559

Creatinine (mg/dL)

2.6 ± 3.1

2.8 ± 3.1

2.5 ± 3.0

0.595

Magnesium (mEq/L)

1.7 ± 0.2

1.7 ± 0.2

1.7 ± 0.3

0.615

  1. Values are mean ± SD (range). HTN indicates hypertension group, Pts patients, AF atrial fibrillation, PTCA percutaneous transluminal coronary angioplasty, HDL high dense lipoprotein, LDL low dense lipoprotein, hs-CRP high sensitive C-reactive protein